However, more anti‐EGFR miRNAs need to be explored, as a single mRNA can be the target of hundreds of miRNAs, and combinations of multiple tumour suppressive miRNAs targeting an individual gene might improve therapeutic efficacy by reducing resistance 17. Here, EGFR is linked to neoplasm.